AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic rhinosinusitis in people with nasal polyps, after the FDA rejected its marketing ...

Frequent colorectal polyp diagnoses in first- and second-degree relatives are associated with an increased risk for colorectal cancer (CRC), especially early-onset CRC. Researchers evaluated the ...

Oxidative Stress: Neuropathy, Excitability, and Neurodegeneration.

Gland Pharma Ltd., incorporated in the year 1978, is a Small Cap company (having a market cap of Rs 24,818.20 Crore) operating in Pharmaceuticals sector. Gland Pharma Ltd. key Products/Revenue ...